Ads
related to: Renal Cell Carcinoma- How This Treatment Works
Learn More About How This
FDA-Approved Treatment Works.
- Dosing Information
Get Dosing And Treatment
Schedule Information.
- FAQs
Find FAQs For This Treatment
Option On The Official Patient Site
- Patient Resources
Find Patient Resources
On The Official Site.
- How This Treatment Works
Search results
Is Moderna Stock A Buy As The Company Eyes The Covid Vaccine Market — Again?
Investor's Business Daily· 16 hours agoNow, Moderna stock is pulling back slightly as it forms a cup-with-handle base, MarketSurge.com...
Myriad Genetics (MYGN) Wins Foundational Patent for MRD Assay
Zacks via Yahoo Finance· 24 hours agoThe company plans to present initial findings from retrospective MRD studies at the upcoming...
Q&A: Dr. Kimryn Rathmell, director of National Cancer Institute
Nashville Post· 3 days agoDr. W. Kimryn Rathmell earned her stripes while working at Vanderbilt University Medical Center....
Courtney Hanneman Of Fredericksburg Dies, 39: 'Pure Love'
Daily Voice· 2 days agoCourtney Hanneman of Fredericksburg died on Tuesday, March 19, according to her obituary on the Mullins & Thompson Funeral Service website. She was 39 years old. Courtney is survived by her husband of 10 years, Timothy, whom …
4 Magnificent Growth Stocks You'll Regret Not Buying in the New Nasdaq Bull Market
Motley Fool via Yahoo Finance· 5 days agoFor a biotech stock like Exelixis, it means highly predictable cash flow year after year. Lead drug...
Vanguard Group Inc. Reduces Position in Exelixis, Inc. (NASDAQ:EXEL)
ETF DAILY NEWS· 6 days agoVanguard Group Inc. cut its position in Exelixis, Inc. (NASDAQ:EXEL – Free Report) by 2.3% during the third quarter, according to the company in its most recent 13F filing with the Securities ...
Florida Cancer Specialists & Research Institute Partners to Host One-of-a-Kind Educational Offering...
WJTV Jackson· 7 days agoFlorida Cancer Specialists & Research Institute, LLC (FCS) is partnering with Research to Practice® for the Third Annual National General Medical Oncology Summit this week in Miami, a comprehensive ...
Myriad Genetics Announces Foundational Patent Granted for Molecular Residual Disease (MRD) with...
Morningstar· 6 days agoMyriad Genetics, Inc., (NASDAQ: MYGN), a leader in genetic testing and precision medicine, today announced that the United States Patent and Trademark Office has issued a patent that will strengthen ...
HUTCHMED (NASDAQ:HCM) Rating Increased to Buy at StockNews.com
ETF DAILY NEWS· 1 day agoHUTCHMED (NASDAQ:HCM – Get Free Report) was upgraded by stock analysts at StockNews.com from a “hold” rating to a “buy” rating in a note issued to investors on Wednesday. Separately, Cantor ...
Alan M. Garber Sells 19,205 Shares of Exelixis, Inc. (NASDAQ:EXEL) Stock
ETF DAILY NEWS· 1 day agoExelixis, Inc. (NASDAQ:EXEL – Get Free Report) Director Alan M. Garber sold 19,205 shares of the stock in a transaction that occurred on Thursday, March 21st. Following the completion of the ...
Ads
related to: Renal Cell Carcinoma